Novartis and Sanofi call for higher drug prices in Europe
This content was published on
Swiss and French pharmaceutical companies Novartis and Sanofi argue that the EU should adjust its drug prices to better align with those in the US.
From Jung to psychedelics: a timeline of Switzerland’s contributions to psychiatry
This content was published on
From the synthesisation of LSD to the commercialisation of antidepressants, Switzerland has played a key role in the understanding and treatment of psychiatry.
Switzerland is home to Europe’s only psychedelics treatment
This content was published on
Doctors at Swiss hospitals and private practices are turning to alternative methods such as psychedelics. But the therapies are costly, rare and sometimes informal.
Swiss medical device maker Ypsomed to sell diabetes business
This content was published on
Bern-based injection device manufacturer Ypsomed announced on Tuesday that it was selling its diabetes-related activities.
Swiss pharma giant Roche to invest $50bn in US within five years
This content was published on
After Novartis, fellow Swiss pharmaceutical company Roche plans to invest up to $50 billion in the US over the next five years.
In Switzerland more people are being referred to electrical therapies or psychedelic-assisted psychotherapy. Are there similar approaches where you live?
